PRM Prim, S.A.
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Prim (BME: PRM)
›
Prim (BME: PRM) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 958 employees.
The shares were at 12.25 EUR on 19 November 2026, down 6.4% over 52 weeks. Its 52-week range is 12.10 EUR to 13.90 EUR: the price is 11.9% below the high and 1.2% above the low.
At a market capitalisation of 207.96M EUR, it trades at 15.9 times trailing earnings and 9.2 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 68% for PRM. It pays a dividend yielding 4.30% (it pays out 64% of its earnings), against a median of 0.93% among the dividend payers in that peer group.
Prim reports return on equity of 12.1%, an operating margin of 6.9% and revenue down 1.0% year over year.
It holds more cash than debt, a net cash position of 6.01M EUR. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 16.75 EUR is 36.7% above the current price.